Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?

QR Code

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?

We evaluated NK cell subsets and functions in previously immunodeficient HIV patients responding to ART. Cytokine receptor mRNA was quantitated in purified CD56+ cells. Data were correlated with CD4+ T-cell counts and IFN? responses to CMV. NK cell IFN? responses to K562 cells and proportions of CD5...

Full description

Bibliographic Details
Main Authors:	Tan, D., Fernandez, S., French, M., Price, Patricia
Format:	Journal Article
Published:	Academic Press 2009
Online Access:	http://hdl.handle.net/20.500.11937/20399

Similar Items

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV
by: Affandi, J., et al.
Published: (2015)

Immunosenescent CD57 +CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART
by: Fernandez, S., et al.
Published: (2011)

CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or ? d T-cells, in HIV patients responding to ART
by: Tanaskovic, S., et al.
Published: (2010)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4(+) T Cells from HIV Patients Receiving ART Is Associated with Poor Proliferative Responses.
by: Tanaskovic, S., et al.
Published: (2016)

Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency onantiretroviral therapy are associated with T-cell activation and senescence
by: Tanaskovic, S., et al.
Published: (2014)

Nadir CD4 T-cell counts continue to influence interferon-? responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency
by: Price, Patricia, et al.
Published: (2008)

Naive and Memory CD4+ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART
by: Tanaskovic, S., et al.
Published: (2016)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

The Use of Humoral Responses as a Marker of CMV Burden in HIV Patients on ART Requires Consideration of T-Cell Recovery and Persistent B-Cell Activation
by: Brunt, S., et al.
Published: (2014)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients
by: Makwana, N., et al.
Published: (2017)

Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD)
by: Tan, D., et al.
Published: (2016)

The immunological footprint of CMV in HIV-1 patients stable on long-term ART
by: Affandi, J., et al.
Published: (2015)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

Thymic tissue is not evident on high-resolution computed tomography and [18F]Fluoro-deoxy-glucose positron emission tomography scans of aviraemic HIV patients with poor recovery of CD4 + T cells
by: Tanaskovic, S., et al.
Published: (2011)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Robust interferon-a and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART
by: Tan, D., et al.
Published: (2011)

Chemokine receptor expression on dendritic cells is normal in HIV-infected patients with a stable response to ART, but chemokine levels remain elevated
by: Lee, S., et al.
Published: (2011)

HIV patients, healthy aging and transplant recipients can reveal the hidden footprints of CMV.
by: Waters, Shelley, et al.
Published: (2018)

The effect of genetic variants affecting NK cell function on cardiovascular health and the burden of CMV
by: Waters, Shelley, et al.
Published: (2017)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD)
by: Tan, D., et al.
Published: (2014)

Genetic variations in loci relevant to natural killer cell function are affected by ethnicity but are generally not correlated with susceptibility to HIV-1
by: Aghafar, M., et al.
Published: (2012)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

The detection of CMV in saliva can mark a systemic infection with CMV in renal transplant recipients
by: Waters, Shelley, et al.
Published: (2019)

Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1+ NK cells
by: Makwana, N., et al.
Published: (2016)

Renal transplant immunosuppression impairs natural killer cell function in Vitro and in vivo
by: Morteau, O., et al.
Published: (2010)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n09kjes3l1tuir8qli4bba62go